1-4 of 4
Laura Clayton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluating Barriers to Enrolment into Multiple Myeloma (MM) Clinical Trials: Results from Health Care Professionals and Patient Survey from the UK Myeloma Research Alliance Equity, Diversity and Inclusivity (EDI) Working Group

Selina J Chavda, Marquita Camilleri, Andrew Hall, Laura Clayton, Fatjon Dekaj, Dunsi Bolarinwa, Chantelle Hughes, Doina Levinte, Eileen M Boyle, Martin F Kaiser, Rachel O'Malley, Emma Williams, Andie Guy, Pinkie Chambers, Sandra CM Quinn, Rakesh Popat
Journal: Blood
Blood (2024) 144 (Supplement 1): 3792.2.
https://doi.org/10.1182/blood-2024-205315
Published: 2024
Journal Articles

Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome - Long-Term Follow-up of the Ukmra Optimum/Muknine Trial

Martin F Kaiser, Andrew Hall, Rachel Phillip, Amy Holroyd, Elsa Ferris, Sadie Roberts, Laura Clayton, Kristian Bowles, Mamta Garg, Anand Lokare, Ruth M de Tute, Mark Drayson, Christina Messiou, Roger G Owen, Richard S Houlston, Graham Jackson, Gordon Cook, Guy Pratt, Sarah R Brown, Matthew W. Jenner
Journal: Blood
Blood (2024) 144 (Supplement 1): 3354.
https://doi.org/10.1182/blood-2024-201086
Published: 2024
Journal Articles

Belantamab Mafodotin Plus Cyclophosphamide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma: Interim Results from the UK Myeloma Research Alliance Prommise Clinical Trial

Rakesh Popat, Charlotte Pawlyn, Robert Cicero, Andrew Hall, Ceri Bygrave, Dean Smith, Simona Degli Esposti, Daniel Frank Larkin, Gordon Cook, Matthew W. Jenner, Martin F Kaiser, Lydia Sarah Hui Lee, Amrutha Sridhar, Marzia Rahman, Hanna Renshaw, Jennifer Ryan, Victoria Ware, Thea Chandler, Laura Clayton, Sadie Roberts, Sarah R Brown, Christopher Parrish
Journal: Blood
Blood (2024) 144 (Supplement 1): 1984.
https://doi.org/10.1182/blood-2024-204055
Published: 2024
Journal Articles

Ultra High-Risk Multiple Myeloma Patients with Multi-Hit Tumours and SKY92 High Risk Signature Are at Increased Risk of Early Relapse Even When Treated with Extended Intensified Induction and Consolidation - Results from the Optimum/Muknine Trial

Martin F. Kaiser, Rachel Phillip, Andrew Hall, Amy Holroyd, Laura Bevington, Ruth M de Tute, Laura Clayton, Sadie Roberts, Graham Jackson, Gordon Cook, Richard S Houlston, Mark Drayson, Roger Owen, Guy Pratt, Sarah R Brown, Matthew W. Jenner
Journal: Blood
Blood (2023) 142 (Supplement 1): 881.
https://doi.org/10.1182/blood-2023-177896
Published: 2023